Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 216

1.

Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis.

Gandhi NR, Nunn P, Dheda K, Schaaf HS, Zignol M, van Soolingen D, Jensen P, Bayona J.

Lancet. 2010 May 22;375(9728):1830-43. doi: 10.1016/S0140-6736(10)60410-2.

PMID:
20488523
2.

Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force.

Centers for Disease Control and Prevention (CDC)..

MMWR Recomm Rep. 2009 Feb 13;58(RR-3):1-43.

3.

Predictors of multidrug- and extensively drug-resistant tuberculosis in a high HIV prevalence community.

Andrews JR, Shah NS, Weissman D, Moll AP, Friedland G, Gandhi NR.

PLoS One. 2010 Dec 29;5(12):e15735. doi: 10.1371/journal.pone.0015735.

4.

Multidrug-resistant and extensively drug-resistant tuberculosis: a review.

Chan ED, Iseman MD.

Curr Opin Infect Dis. 2008 Dec;21(6):587-95. doi: 10.1097/QCO.0b013e328319bce6. Review.

PMID:
18978526
5.

Management of difficult multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: update 2012.

Chang KC, Yew WW.

Respirology. 2013 Jan;18(1):8-21. doi: 10.1111/j.1440-1843.2012.02257.x. Review.

6.

Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa.

Streicher EM, Müller B, Chihota V, Mlambo C, Tait M, Pillay M, Trollip A, Hoek KG, Sirgel FA, Gey van Pittius NC, van Helden PD, Victor TC, Warren RM.

Infect Genet Evol. 2012 Jun;12(4):686-94. doi: 10.1016/j.meegid.2011.07.019. Epub 2011 Aug 4. Review.

PMID:
21839855
7.

Multidrug and extensively drug-resistant TB (M/XDR-TB): problems and solutions.

Prasad R.

Indian J Tuberc. 2010 Oct;57(4):180-91. Review.

PMID:
21141336
8.

The imminent threat of multidrug-resistant tuberculosis in Singapore.

Chee CB, Khin-Mar KW, Cutter J, Wang YT.

Singapore Med J. 2012 Apr;53(4):238-40.

9.

Household contact investigation of multidrug-resistant and extensively drug-resistant tuberculosis in a high HIV prevalence setting.

Vella V, Racalbuto V, Guerra R, Marra C, Moll A, Mhlanga Z, Maluleke M, Mhlope H, Margot B, Friedland G, Shah NS, Gandhi NR.

Int J Tuberc Lung Dis. 2011 Sep;15(9):1170-5, i. doi: 10.5588/ijtld.10.0781.

PMID:
21943840
10.

Clinical management of adults and children with multidrug-resistant and extensively drug-resistant tuberculosis.

Dheda K, Chang KC, Guglielmetti L, Furin J, Schaaf HS, Chesov D, Esmail A, Lange C.

Clin Microbiol Infect. 2017 Mar;23(3):131-140. doi: 10.1016/j.cmi.2016.10.008. Epub 2016 Oct 15. Review.

PMID:
27756712
11.

Drug-resistant tuberculosis: past, present, future.

Chiang CY, Centis R, Migliori GB.

Respirology. 2010 Apr;15(3):413-32. doi: 10.1111/j.1440-1843.2010.01738.x. Epub 2010 Mar 19. Review.

PMID:
20337989
12.

Tuberculosis burden in households of patients with multidrug-resistant and extensively drug-resistant tuberculosis: a retrospective cohort study.

Becerra MC, Appleton SC, Franke MF, Chalco K, Arteaga F, Bayona J, Murray M, Atwood SS, Mitnick CD.

Lancet. 2011 Jan 8;377(9760):147-52. doi: 10.1016/S0140-6736(10)61972-1. Epub 2010 Dec 8.

PMID:
21145581
13.

Development of a standardised multidrug-resistant/extensively drug-resistant tuberculosis assessment and monitoring tool.

Migliori GB, Sotgiu G, Jaramillo E, Mirzayev F, Centis R, Colvin C, Richardson MD.

Int J Tuberc Lung Dis. 2009 Oct;13(10):1305-8.

PMID:
19793438
14.
15.

Multidrug-resistant tuberculosis.

Zager EM, McNerney R.

BMC Infect Dis. 2008 Jan 25;8:10. doi: 10.1186/1471-2334-8-10.

16.

Multidrug-resistant TB in Zambia: review of national data from 2000 to 2011.

Kapata N, Chanda-Kapata P, Bates M, Mwaba P, Cobelens F, Grobusch MP, Zumla A.

Trop Med Int Health. 2013 Nov;18(11):1386-91. doi: 10.1111/tmi.12183. Epub 2013 Sep 11.

17.

Multidrug-resistant and extensively drug-resistant tuberculosis in multi-ethnic region, Xinjiang Uygur Autonomous Region, China.

Qi YC, Ma MJ, Li DJ, Chen MJ, Lu QB, Li XJ, Li JL, Liu W, Cao WC.

PLoS One. 2012;7(2):e32103. doi: 10.1371/journal.pone.0032103. Epub 2012 Feb 22.

18.

Drug-resistant tuberculosis: an insurmountable epidemic?

Chakroborty A.

Inflammopharmacology. 2011 Jun;19(3):131-7. doi: 10.1007/s10787-010-0072-2. Epub 2010 Dec 3. Review.

PMID:
21127999
19.

Management of drug resistantTB in patients with HIV co-infection.

Pontali E, Sotgiu G, Centis R, D'Ambrosio L, Spanevello A, Migliori GB.

Expert Opin Pharmacother. 2015;16(18):2737-50. doi: 10.1517/14656566.2015.1100169. Epub 2015 Oct 19. Review.

PMID:
26478945
20.

Incidence and risk factors for extensively drug-resistant tuberculosis in Delhi region.

Porwal C, Kaushik A, Makkar N, Banavaliker JN, Hanif M, Singla R, Bhatnagar AK, Behera D, Pande JN, Singh UB.

PLoS One. 2013;8(2):e55299. doi: 10.1371/journal.pone.0055299. Epub 2013 Feb 4.

Supplemental Content

Support Center